Clinical Trial Update: A Phase 1 Study Evaluating DISP-10 in Participants With Advanced Gastrointestinal Cancers [Phase 1]

View source ↗

Summary

This update details a Phase 1 study evaluating DISP-10 in advanced gastrointestinal cancers, with the trial currently not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer
• Esophageal Adenocarcinoma
• Gastric Adenocarcinoma
• Gastroesophageal Adenocarcinoma

Drugs mentioned

• DISP-10

Snippet

Sponsor: Dispatch Biotherapeutics | Conditions: Colorectal Cancer, Gastric Adenocarcinoma | Phase 1 | Status: NOT_YET_RECRUITING